Dietary Supplement
Viusid®
Viusid® is a dietary supplement with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DIETARY SUPPLEMENT
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
3
50%
Ph phase_2
3
50%
Phase Distribution
0
Early Stage
3
Mid Stage
3
Late Stage
Phase Distribution6 total trials
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
3(50.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(5)
Other(1)
Detailed Status
Completed5
Suspended1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 23 (50.0%)
Phase 33 (50.0%)
Trials by Status
suspended117%
completed583%
Recent Activity
0 active trials
Showing 5 of 6
completedphase_2
Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19
NCT04701502
completedphase_2
Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal
NCT03584308
completedphase_3
Antioxidant and Immunomodulator Properties of Viusid in Patients With Chronic Hepatitis C
NCT00778843
suspendedphase_3
Viusid Administration in Subjects With Chronic Inflammatory Syndrome Under Hemodialysis Treatment
NCT00978224
completedphase_2
Viusid in Adults With Acute Fever of Viral Etiology
NCT01008007
Clinical Trials (6)
Showing 6 of 6 trials
NCT04701502Phase 2
Efficacy and Safety of Viusid and Asbrip in Hospitalized Patients With Mild and Moderate COVID-19
NCT03584308Phase 2
Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus Esophageal
NCT00778843Phase 3
Antioxidant and Immunomodulator Properties of Viusid in Patients With Chronic Hepatitis C
NCT00978224Phase 3
Viusid Administration in Subjects With Chronic Inflammatory Syndrome Under Hemodialysis Treatment
NCT01008007Phase 2
Viusid in Adults With Acute Fever of Viral Etiology
NCT00509418Phase 3
Efficacy and Safety of Viusid in Patients With Nonalcoholic Steatohepatitis
All 6 trials loaded
Drug Details
- Intervention Type
- DIETARY SUPPLEMENT
- Total Trials
- 6